Publications by authors named "Marcella Fasso"

Claim this Profile
P
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.
Shilpa Gupta, Alexander Andreev-Drakhlin, Otto Fajardo, Marcella Fassò, Jorge A Garcia

J Natl Cancer Inst· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
Mahrukh A Huseni, Lifen Wang, Joanna E Klementowicz, Kobe Yuen, Beatrice Breart

Cell Rep Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Raghav Sundar, Kie-Kyon Huang, Vikrant Kumar, Kalpana Ramnarayanan, Deniz Demircioglu, Marcella Fasso

Gut· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
Daniel P Petrylak, Yohann Loriot, David R Shaffer, Fadi Braiteh, John Powderly

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
Anne C Chiang, Lecia Van Dam Sequist, Jill Gilbert, Paul Conkling, Dana Thompson

Clin Lung Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response.
Omid Hamid, Rene Bruno, Marcella Fasso, Carol O'Hear, Benjamin Wu

Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.
Omid Hamid, Luciana Molinero, Christopher R Bolen, Jeffrey A Sosman, Eva Muñoz-Couselo

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.
Luciana Molinero, Yijin Li, Ching-Wei Chang, Sophia Maund, Maureen Berg

J Immunother Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers.
Joyce F Liu, Michael Gordon, Jennifer Veneris, Fadi Braiteh, Ani Balmanoukian

Gynecol Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.
Chien-Chun Steven Pai, John T Huang, Xiaoqing Lu, Donald M Simons, Chanhyuk Park, Marcella Fasso

Immunity· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
Leisha A Emens, Cristina Cruz, Joseph Paul Eder, Fadi Braiteh, Cathie Chung

JAMA Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis.
Leisha A Emens, S Lindsey Davis, Scott C N Oliver, Christopher H Lieu, Ashvini Reddy

JAMA Ophthalmol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
Rimas V Lukas, Jordi Rodon, Kevin Becker, Eric T Wong, Kent Shih

J Neurooncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study.
Leora Horn, Scott N Gettinger, Michael S Gordon, Roy S Herbst, Leena Gandhi

Eur J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study.
Daniel P Petrylak, Thomas Powles, Joaquim Bellmunt, Fadi Braiteh, Yohann Loriot

JAMA Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study.
David F McDermott, Jeffrey A Sosman, Mario Sznol, Christophe Massard, Michael S Gordon

J Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection.
Rebecca Waitz, Marcella Fassò, James P Allison

Oncoimmunology· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
Meili Zhang, Wei Ju, Zhengsheng Yao, Ping Yu, Bih-Rong Wei

J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Ping Yu, Jason C Steel, Meili Zhang, John C Morris, Rebecca Waitz, Marcella Fasso

Proc Natl Acad Sci U S A· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.
Rebecca Waitz, Stephen B Solomon, Elena N Petre, Anne E Trumble, Marcella Fassò

Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
Marcella Fassò, Rebecca Waitz, Yafei Hou, Tae Rim, Norman M Greenberg

Proc Natl Acad Sci U S A· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis